Free Cash Flow (Quarterly) Chart

View Free Cash Flow (Quarterly) for PRAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow (Quarterly) Chart
Start Trial

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -78.21M
March 31, 2026 -86.11M
December 31, 2025 -77.26M
September 30, 2025 -64.74M
June 30, 2025 -54.42M
March 31, 2025 -52.71M
December 31, 2024 -56.96M
September 30, 2024 -27.21M
June 30, 2024 -27.00M
March 31, 2024 -20.59M
December 31, 2023 -23.65M
September 30, 2023 -22.96M
June 30, 2023 -30.96M
March 31, 2023 -32.61M
Date Value
December 31, 2022 -28.57M
September 30, 2022 -44.74M
June 30, 2022 -56.99M
March 31, 2022 -54.37M
December 31, 2021 -45.19M
September 30, 2021 -24.22M
June 30, 2021 -29.89M
March 31, 2021 -25.54M
December 31, 2020 -20.05M
September 30, 2020 -13.71M
June 30, 2020 -9.773M
March 31, 2020 -8.40M
December 31, 2019 -9.789M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Heron Therapeutics, Inc. -2.351M
Insmed, Inc. -95.09M
Ionis Pharmaceuticals, Inc. 547.30M
Perspective Therapeutics, Inc. -34.87M
Regeneron Pharmaceuticals, Inc. 521.80M